Moreover, TF-expressing monocytes, that were found to be mildly increased in symptomatic vs. asymptomatic patients (30), were not different here between patient groups; hence, the role of serum or cell surface-expressed TF as a predictive marker of thrombo-embolism in patients with COVID-19 remains debatable. This evidence concerns the gene TF and COVID-19.